INTERPACE BIOSCIENCES, INC. (IDXG) Free cash flow 2017–2025
INTERPACE BIOSCIENCES, INC. (IDXG) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$5.5MFY2025 · since FY2017: -$15.3M → $5.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.5M | +45.2% |
| FY2024 | $3.8M | +13.6% |
| FY2023 | $3.3M | +141.4% |
| FY2022 | -$8.0M | +11.7% |
| FY2021 | -$9.1M | +41.7% |
| FY2020 | -$15.6M | +18.5% |
| FY2019 | -$19.1M | -109.3% |
| FY2018 | -$9.1M | +40.3% |
| FY2017 | -$15.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice